This letter outlines the potential use of a three-component solvent, with strong anti-viral properties, as an economical and efficient treatment of COVID-19. It focuses on the generation and delivery of the alcohol-based solvent as nanodroplets deep within a patients lungs to reduce the viral load and potentially reduce the impact of a bradykinin or cytokine storm. The treatment is considered for compassionate use where other methods are not available or will not work.
Author and article information
] Valdosta State University, USA
] Forrest General Hospital and Hattiesburg Clinic, USA
This work has been published open access under Creative Commons Attribution License
CC BY 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided
can be found at
Data availability: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.